HolderBook

BIOLINE RX LIMITED (BLRX)

Institutional ownership reported to the SEC as of Q2 2026, across 29 quarters.

13
Reporting holders
$327.6K
Reported value
0.0%
Of shares outstanding
36.9%
Held as options
+1
Holder change

Institutions report 66,569 shares against 2,610,814,390 outstanding. Shares only - option lines are excluded, which is why this can be compared with the company at all. The count comes from the cover page of the company's own most recent report, so it is dated when that was filed rather than at quarter end. Share count carried from an earlier filing (cy2026q1i).

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
SUSQUEHANNA INTERNATIONAL GROUP, LLP$216.7K30,9110.00%2qHELD
RENAISSANCE TECHNOLOGIES LLC$48.1K15,4120.00%newNEW
CITADEL ADVISORS LLC$45.9K14,7960.00%newNEW
RHUMBLINE ADVISERS$7.7K2,4780.00%6q+5.3%
WELLS FARGO & COMPANY/MN$6.2K2,0000.00%6q-42.9%-$4.7K
BNP PARIBAS FINANCIAL MARKETS$1.6K5000.00%3q-72.2%-$4.0K
Banque Cantonale Vaudoise$1.0K10.00%newNEW
Nemes Rush Group LLC$7802500.00%6qHELD
UBS Group AG$3151010.00%4q-80.9%-$1.3K
NewEdge Advisors, LLC$256820.00%newNEW
OSAIC HOLDINGS, INC.$81260.00%5qHELD
SBI Securities Co., Ltd.$31100.00%newNEW
DANSKE BANK A/S$620.00%6qHELD
CITIGROUP INC$310.00%3q-99.9%-$5.2K

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q2 202613$327.6K66,56941436.9%
Q1 202612$72.6K21,24122332.5%
Q4 202514$203.2K47,75024233.2%
Q3 202515$182.9K27,59531343.0%
Q2 202518$879.7K52,102121372.9%
Q1 202512$28.0K9,46012000.0%
Q4 202431$450.9K2,046,0548663.8%
Q3 202434$1.4M2,476,38348102.4%
Q2 202433$2.5M4,256,2456964.1%
Q1 202428$2.4M1,883,37349710.4%
Q4 202328$2.6M1,345,54825918.9%
Q3 202329$3.5M1,318,51697530.8%
Q2 202324$2.1M1,113,757102413.4%
Q1 202318$2.8M3,179,5814220.0%
Q4 202214$3.2M5,420,5402270.0%
Q3 202226$10.3M11,166,4007560.2%
Q2 202227$1.4M1,061,0825373.5%
Q1 202226$2.1M1,162,8774563.2%
Q4 202130$5.4M2,564,83941043.8%
Q3 202130$7.1M2,433,2346655.9%
Q2 202130$4.2M1,424,5438284.2%
Q1 202128$13.5M4,822,24911820.0%
Q4 202019$4.6M1,826,9358330.0%
Q3 202016$6.7M4,055,3074430.0%
Q2 202014$5.4M3,169,4337320.0%
Q1 20209$3.7M2,750,3332220.0%
Q4 20199$6.1M2,713,4112210.0%
Q3 201912$6.6M2,513,61112000.0%
Q2 20191$5.0K12,7121000.0%